Zeb1 and twist are more commonly expressed in metastatic than primary lung tumours and show inverse associations with claudins

Journal of Clinical Pathology

Volumn 64, Issue 2, 2011, Pages 136-140

  Merikallio, Heta ^a   Kaarteenaho, Riitta ^a,b   Pääkkö, Paavo ^a   Lehtonen, Siri ^a   Hirvikoski, Pasi ^a   Mäkitaro, Riitta ^a   Harju, Terttu ^a,b   Soini, Ylermi ^c  

^a OULU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF OULU   (Finland)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CLAUDIN 1; CLAUDIN 4; CLAUDIN 5; CLAUDIN 7; TRANSCRIPTION FACTOR TWIST; ZINC FINGER PROTEIN;

ARTICLE; DOWN REGULATION; IMMUNOHISTOCHEMISTRY; LUNG CARCINOMA; LUNG TUMOR; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL;

ADENOCARCINOMA; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; CLAUDINS; HOMEODOMAIN PROTEINS; HUMANS; LUNG NEOPLASMS; NEOPLASM PROTEINS; NUCLEAR PROTEINS; TRANSCRIPTION FACTORS; TWIST TRANSCRIPTION FACTOR;

EID: 79151478291     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2010.086678     Document Type: Article

References (31)

1. Schmalhofer O, Brabletz S, Brabletz T. E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer. Cancer Metastasis Rev 2009;28:151-66.
2. De Wever O, Pauwels P, De Craene B, et al. Molecular and pathological signatures of epithelial-mesenchymal transitions at the cancer invasion front. Histochem Cell Biol 2008;130:481-94.
3. Singh M, Spoelstra NS, Jean A, et al. ZEB1 expression in type I vs type II endometrial cancers: a marker of aggressive disease. Mod Pathol 2008;21:912-23.
4. Hurt EM, Saykally JN, Anose BM, et al. Expression of the ZEB1 (deltaEF1) transcription factor in human: additional insights. Mol Cell Biochem 2008;318:89-99.
5. Katoh Y, Katoh M. Hedgehog target genes: mechanisms of carcinogenesis induced by aberrant hedgehog signaling activation. Curr Mol Med 2009;9:873-86.
6. Korpal M, Lee ES, Hu G, et al. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem 2008;283:14910-14.
7. Vandewalle C, Van Roy F, Berx G. The role of the ZEB family of transcription factors in development and disease. Cell Mol Life Sci 2009;66:773-87.
8. Matsuo N, Shiraha H, Fujikawa T, et al. Twist expression promotes migration and invasion in hepatocellular carcinoma. BMC Cancer 2009;9:240.
9. Spaderna S, Schmalhofer O, Wahlbuhl M, et al. The transcriptional repressor ZEB1 promotes metastasis and loss of cell polarity in cancer. Cancer Res 2008;68:537-44.
10. Lee TK, Poon RT, Yuen AP, et al. Twist overexpression correlates with hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition. Clin Cancer Res 2006;12:5369-76.
11. Kwok WK, Ling MT, Lee TW, et al. Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target. Cancer Res 2005;65:5153-62.
12. Pena W, Slavotinek A, Oberoi S. Saethre-Chotzen syndrome: a case report. Cleft Palate Craniofac J 2009;14:1.
13. Förster C. Tight junctions and the modulation of barrier function in disease. Histochem Cell Biol 2008;130:55-70.
14. Krause G, Winkler R, Mueller SL, et al. Structure and function of claudins. Biochimica et Biophysica Acta 2008;1778:631-45.
15. Soini Y. Expression of claudins 1, 2, 3, 4, 5 and 7 in various types of tumours. Histopathology 2005;46:551-60.
16. Soini Y, Kinnula V, Kahlos K, et al. Claudins in differential diagnosis between mesothelioma and metastatic adenocarcinoma of the pleura. J Clin Pathol 2006;59:250-4.
17. Väre P, Loikkanen I, Hirvikoski P, et al. Low claudin expression is associated with high Gleason grade in prostate adenocarcinoma. Oncol Rep 2008;19:25-31. (Pubitemid 351176127)
18. Soini Y, Tommola S, Helin H, et al. Claudin 1, 3, 4 and 5 in gastric carcinoma, loss of claudin expression associates with the diffuse subtype. Virchows Arch 2006;448:52-8.
19. Soini Y. Claudins 2, 3, 4 and 5 in Paget's disease and breast carcinoma. Hum Pathol 2004;35:1531-6.
20. Takala H, Saarnio J, Wiik H, et al. Claudins 1, 3, 4, 5 and 7 in esophageal cancer: loss of claudin 3 and 4 expression is associated with metastatic behavior. APMIS 2007;115:838-47.
21. Travis WD, Brambilla E, Muller-Hermelink HK, et al. Tumours of the Lung, Pleura, Thymus and heart. Pathology & Genetics. WHO Classification of tumours. Lyon, France: IARC Press, 2004.
22. Spoelstra NS, Manning NG, Higashi Y, et al. The transcription factor ZEB1 is aberrantly expressed in aggressive uterine cancers. Cancer Res 2006;66:3893-902.
23. Sayan AE, Griffiths TR, Pal R, et al. SIP1 protein protects cells from DNA damage-induced apoptosis and has independent prognostic value in bladder cancer. Proc Natl Acad Sci U S A 2009;106:14884-9.
24. Shibata K, Kajiyama H, Ino K, et al. Twist expression in patients with cervical cancer is associated with poor disease outcome. Ann Oncol 2008;19:81-5.
25. Sasaki K, Natsugoe S, Ishigami S, et al. Significance of twist expression and its association with E-cadherin in esophageal squamous cell carcinoma. J Exp Clin Cancer Res 2009;28:158.
26. Vyas-Read S, Shaul PW, Yuhanna IS, et al. Nitric oxide attenuates epithelial-mesenchymal transition in alveolar epithelial cells. Am J Physiol Lung Cell Mol Physiol 2007;293:L212-21.
27. Kalluri R, Weisberg RA. The basics of epitheliomesenchymal transition. J Clin Invest 2009;119:1420-8.
28. Ikenouchi J, Matsuda M, Furuse M, et al. Regulation of tight junctions during the epithelium-mesenchyme transition: direct repression of the gene expression of claudins/occludin by Snail. J Cell Sci 2003;116:1959-67.
29. Sormunen R, Pääkkö P, Kaarteenaho-Wiik R, et al. Differential expression of adhesion molecules in lung tumours. Histopathology 2007;50:282-4. (Pubitemid 46046399)
30. Moldway J, Jäckel M, Páska C, et al. Distinct claudin expression profle in histologic subtypes of lung cancer. J Lung Cancer 2007;57:159-67. (Pubitemid 47043180)
31. Kaarteenaho-Wiik R, Soini Y. Claudin-1, -2, -3, -4, -5, and -7 in usual interstitial pneumonia and sarcoidosis. J Histochem Cytochem 2009;3:187-95.